196 related articles for article (PubMed ID: 18079053)
1. Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.
Kang HC; Kim IJ; Jang SG; Hong SH; Hwang JA; Shin HR; Park JG
Cancer Lett; 2008 Feb; 260(1-2):170-9. PubMed ID: 18079053
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population.
Yamamoto H; Hanafusa H; Ouchida M; Yano M; Suzuki H; Murakami M; Aoe M; Shimizu N; Nakachi K; Shimizu K
Carcinogenesis; 2005 Feb; 26(2):411-6. PubMed ID: 15550454
[TBL] [Abstract][Full Text] [Related]
3. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
[TBL] [Abstract][Full Text] [Related]
4. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
Potocnik U; Glavac D; Dean M
Cancer Genet Cytogenet; 2008 May; 183(1):28-34. PubMed ID: 18474294
[TBL] [Abstract][Full Text] [Related]
5. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D
Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the CHFR gene in digestive tract cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
[TBL] [Abstract][Full Text] [Related]
13. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
Ohnami S; Sato Y; Yoshimura K; Ohnami S; Sakamoto H; Aoki K; Ueno H; Ikeda M; Morizane C; Shimada K; Sakamoto Y; Esaki M; Saito I; Hirose H; Saito D; Sugimura H; Kosuge T; Okusaka T; Yoshida T
Gastroenterology; 2008 Aug; 135(2):477-88. PubMed ID: 18515090
[TBL] [Abstract][Full Text] [Related]
14. PTPRJ haplotypes and colorectal cancer risk.
Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
[TBL] [Abstract][Full Text] [Related]
15. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.
Mariatos G; Bothos J; Zacharatos P; Summers MK; Scolnick DM; Kittas C; Halazonetis TD; Gorgoulis VG
Cancer Res; 2003 Nov; 63(21):7185-9. PubMed ID: 14612512
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of CHFR in human tumors.
Toyota M; Sasaki Y; Satoh A; Ogi K; Kikuchi T; Suzuki H; Mita H; Tanaka N; Itoh F; Issa JP; Jair KW; Schuebel KE; Imai K; Tokino T
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7818-23. PubMed ID: 12810945
[TBL] [Abstract][Full Text] [Related]
17. The human leukocyte antigen region and colorectal cancer risk.
de Jong MM; Niens M; Nolte IM; te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
Dis Colon Rectum; 2005 Feb; 48(2):303-6. PubMed ID: 15714243
[TBL] [Abstract][Full Text] [Related]
18. Chfr inactivation is not associated to chromosomal instability in colon cancers.
Bertholon J; Wang Q; Falette N; Verny C; Auclair J; Chassot C; Navarro C; Saurin JC; Puisieux A
Oncogene; 2003 Dec; 22(55):8956-60. PubMed ID: 14654793
[TBL] [Abstract][Full Text] [Related]
19. CHFR gene is neither mutated nor hypermethylated in ovarian cancer.
Ludwig AH; Bujko M; Bidzinski M; Kupryjańczyk J
Cancer Detect Prev; 2007; 31(3):257-61. PubMed ID: 17673375
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
